Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07855718) titled 'Serum Soluble BCMA as a Non-Invasive Marker in Multiple Myeloma' on Sept. 28.
Study Type: Observational
Primary Sponsor: Assiut University
Condition:
Multiple Myeloma
Recruitment Status: Not recruiting
Date of First Enrollment: September 30, 2026
Target Sample Size: 90
To know more, visit https://clinicaltrials.gov/study/NCT07855718
Published by HT Digital Content Services with permission from Health Daily Digest....